有效的全身阻断内源性一氧化氮的产生导致健康志愿者中度高血压、交感神经活动减少和出血时间缩短。

J Albert
{"title":"有效的全身阻断内源性一氧化氮的产生导致健康志愿者中度高血压、交感神经活动减少和出血时间缩短。","authors":"J Albert","doi":"10.1111/j.1399-6576.1997.tb05542.x","DOIUrl":null,"url":null,"abstract":"Background Nitric oxide (NO) is of fundamental importance in the regulation of the circulatory system. NO is synthesised in the endothelium, as well as in many other sites, and has been shown to be a potent vasodilator. It is also an important inhibitor of platelet function. The endogenous production of NO from its precursor L-arginine can be reduced by intravenous infusion of L-arginine analogues, like NGmonomethyl-L-arginine (L-NMMA). Short term infusion of L-NMMA is known to reversibly inhibit endogenous NO production in humans. L-NMMA (0.6 mg/kg/min) has previously been given to volunteers as 5 min infusions (Haynes et al, J Hypertens. 19931, and resulted in vasoconstriction as reflected by changes in several haemodynamic parameters. The effects were maximal 5-10 min after the L-NMMA infusion. Patients with increased NO production, such as patients with sepsis, have been treated with LNMMA, (0.017 mg/kg/&), during longer periods of time (6 hours) to restore vascular tone (Petros et al. Cardiovasc Res. 19941, but long lasting infusion in healthy individuals have not been reported. We studied 60 minutes infusion of L-NMMA in healthy volunteers. We attempted to establish sustained mild systemic hypertension, as evidence of partial and stable blockade of endogenous NO production, enabling future intervention studies. We specifically examined hemodynamic responses, including the pulmonary circulation and markers of sympathetic nervous system activity (i.e. catecholamines in plasma). We also studied parameters that might reflect the degree of inhibition of endogenous NO production, such as NO concentrations in nasal air, bleeding time (i.e. primary haemostasis) and plasma concentrations of cyclic guanosinmonophosphate (&MI'). Methods Eight healthy male volunteers, ages ranged from 18 to 23, partiapated in the study. Young healthy males were specifically recruited for safety reasons. All subjects rested for 30 minutes in the supine position after catheter (pulmonary, arterial and ankle vein) placement to establish a stable baseline. Baseline measurements were performed. During the experiment 500 ml 0.9% NaCl solution was infused via the ankle catheter, and through this catheter LNMMA was given intravenously with an infusion pump. The dose of L-NMMA was 0.3 mg/kg/min during 30 min, followed by 0.15 mg/kg/min during 30 min (n=6), or 0.3 mg/kg/min for 60 min (n=2). Haemodynamic and forearm blood flow measurements in the fore arm were repeated during (5, 15,30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Bleeding time was measured during (15 and 50 min) the infusion. Concentration of NO in nasal air (eNO) were determined during (15, 30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Blood sampling (PaO,, Sa02 PVO,, SVO,, as well as cGMP and cathecolamines in plasma) was repeated during (5, 15, 30 and 50 min) and after (+30 and +60 min) L-NMMA. The study was approved by the Ethics Committee of the Karolinska Hospital and the Swedish Medical Products Agency. Results The lower dose (se above) of L-NMMA a p peared to be safe and well tolerated, with only minor complaints of lower back pain, described as tiredness. L-NMNU significantly elevated mean arterial pressure by 12%*3%, due to an increase in systemic vascular resistance. Cardiac output decreased by 23%*3%. Heart rate was stable during infusion and increased slightly after the infusion. Mean pulmonary arterial pressure was stable while pulmonary vascular resistance tended to increase. Surprisingly, forearm vascular resistance decreased slightly, and forearm blood flow increased during the infusion despite the decrease in cardiac output. Bleeding time was shortened by 31 %*4%. LNMMA infusion decreased eNO by 64%*2% and eNO remained decreased more","PeriodicalId":75373,"journal":{"name":"Acta anaesthesiologica Scandinavica. Supplementum","volume":"110 ","pages":"159-60"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1399-6576.1997.tb05542.x","citationCount":"3","resultStr":"{\"title\":\"Effective systemic blockade of endogenous nitric oxide production results in moderate hypertension, reduced sympathetic activity and shortened bleeding time in healthy volunteers.\",\"authors\":\"J Albert\",\"doi\":\"10.1111/j.1399-6576.1997.tb05542.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Nitric oxide (NO) is of fundamental importance in the regulation of the circulatory system. NO is synthesised in the endothelium, as well as in many other sites, and has been shown to be a potent vasodilator. It is also an important inhibitor of platelet function. The endogenous production of NO from its precursor L-arginine can be reduced by intravenous infusion of L-arginine analogues, like NGmonomethyl-L-arginine (L-NMMA). Short term infusion of L-NMMA is known to reversibly inhibit endogenous NO production in humans. L-NMMA (0.6 mg/kg/min) has previously been given to volunteers as 5 min infusions (Haynes et al, J Hypertens. 19931, and resulted in vasoconstriction as reflected by changes in several haemodynamic parameters. The effects were maximal 5-10 min after the L-NMMA infusion. Patients with increased NO production, such as patients with sepsis, have been treated with LNMMA, (0.017 mg/kg/&), during longer periods of time (6 hours) to restore vascular tone (Petros et al. Cardiovasc Res. 19941, but long lasting infusion in healthy individuals have not been reported. We studied 60 minutes infusion of L-NMMA in healthy volunteers. We attempted to establish sustained mild systemic hypertension, as evidence of partial and stable blockade of endogenous NO production, enabling future intervention studies. We specifically examined hemodynamic responses, including the pulmonary circulation and markers of sympathetic nervous system activity (i.e. catecholamines in plasma). We also studied parameters that might reflect the degree of inhibition of endogenous NO production, such as NO concentrations in nasal air, bleeding time (i.e. primary haemostasis) and plasma concentrations of cyclic guanosinmonophosphate (&MI'). Methods Eight healthy male volunteers, ages ranged from 18 to 23, partiapated in the study. Young healthy males were specifically recruited for safety reasons. All subjects rested for 30 minutes in the supine position after catheter (pulmonary, arterial and ankle vein) placement to establish a stable baseline. Baseline measurements were performed. During the experiment 500 ml 0.9% NaCl solution was infused via the ankle catheter, and through this catheter LNMMA was given intravenously with an infusion pump. The dose of L-NMMA was 0.3 mg/kg/min during 30 min, followed by 0.15 mg/kg/min during 30 min (n=6), or 0.3 mg/kg/min for 60 min (n=2). Haemodynamic and forearm blood flow measurements in the fore arm were repeated during (5, 15,30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Bleeding time was measured during (15 and 50 min) the infusion. Concentration of NO in nasal air (eNO) were determined during (15, 30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Blood sampling (PaO,, Sa02 PVO,, SVO,, as well as cGMP and cathecolamines in plasma) was repeated during (5, 15, 30 and 50 min) and after (+30 and +60 min) L-NMMA. The study was approved by the Ethics Committee of the Karolinska Hospital and the Swedish Medical Products Agency. Results The lower dose (se above) of L-NMMA a p peared to be safe and well tolerated, with only minor complaints of lower back pain, described as tiredness. L-NMNU significantly elevated mean arterial pressure by 12%*3%, due to an increase in systemic vascular resistance. Cardiac output decreased by 23%*3%. Heart rate was stable during infusion and increased slightly after the infusion. Mean pulmonary arterial pressure was stable while pulmonary vascular resistance tended to increase. Surprisingly, forearm vascular resistance decreased slightly, and forearm blood flow increased during the infusion despite the decrease in cardiac output. Bleeding time was shortened by 31 %*4%. LNMMA infusion decreased eNO by 64%*2% and eNO remained decreased more\",\"PeriodicalId\":75373,\"journal\":{\"name\":\"Acta anaesthesiologica Scandinavica. Supplementum\",\"volume\":\"110 \",\"pages\":\"159-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1399-6576.1997.tb05542.x\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta anaesthesiologica Scandinavica. Supplementum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/j.1399-6576.1997.tb05542.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta anaesthesiologica Scandinavica. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1399-6576.1997.tb05542.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Effective systemic blockade of endogenous nitric oxide production results in moderate hypertension, reduced sympathetic activity and shortened bleeding time in healthy volunteers.
Background Nitric oxide (NO) is of fundamental importance in the regulation of the circulatory system. NO is synthesised in the endothelium, as well as in many other sites, and has been shown to be a potent vasodilator. It is also an important inhibitor of platelet function. The endogenous production of NO from its precursor L-arginine can be reduced by intravenous infusion of L-arginine analogues, like NGmonomethyl-L-arginine (L-NMMA). Short term infusion of L-NMMA is known to reversibly inhibit endogenous NO production in humans. L-NMMA (0.6 mg/kg/min) has previously been given to volunteers as 5 min infusions (Haynes et al, J Hypertens. 19931, and resulted in vasoconstriction as reflected by changes in several haemodynamic parameters. The effects were maximal 5-10 min after the L-NMMA infusion. Patients with increased NO production, such as patients with sepsis, have been treated with LNMMA, (0.017 mg/kg/&), during longer periods of time (6 hours) to restore vascular tone (Petros et al. Cardiovasc Res. 19941, but long lasting infusion in healthy individuals have not been reported. We studied 60 minutes infusion of L-NMMA in healthy volunteers. We attempted to establish sustained mild systemic hypertension, as evidence of partial and stable blockade of endogenous NO production, enabling future intervention studies. We specifically examined hemodynamic responses, including the pulmonary circulation and markers of sympathetic nervous system activity (i.e. catecholamines in plasma). We also studied parameters that might reflect the degree of inhibition of endogenous NO production, such as NO concentrations in nasal air, bleeding time (i.e. primary haemostasis) and plasma concentrations of cyclic guanosinmonophosphate (&MI'). Methods Eight healthy male volunteers, ages ranged from 18 to 23, partiapated in the study. Young healthy males were specifically recruited for safety reasons. All subjects rested for 30 minutes in the supine position after catheter (pulmonary, arterial and ankle vein) placement to establish a stable baseline. Baseline measurements were performed. During the experiment 500 ml 0.9% NaCl solution was infused via the ankle catheter, and through this catheter LNMMA was given intravenously with an infusion pump. The dose of L-NMMA was 0.3 mg/kg/min during 30 min, followed by 0.15 mg/kg/min during 30 min (n=6), or 0.3 mg/kg/min for 60 min (n=2). Haemodynamic and forearm blood flow measurements in the fore arm were repeated during (5, 15,30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Bleeding time was measured during (15 and 50 min) the infusion. Concentration of NO in nasal air (eNO) were determined during (15, 30 and 50 min) and after (+30, +60 and +90 min) LNMMA infusion. Blood sampling (PaO,, Sa02 PVO,, SVO,, as well as cGMP and cathecolamines in plasma) was repeated during (5, 15, 30 and 50 min) and after (+30 and +60 min) L-NMMA. The study was approved by the Ethics Committee of the Karolinska Hospital and the Swedish Medical Products Agency. Results The lower dose (se above) of L-NMMA a p peared to be safe and well tolerated, with only minor complaints of lower back pain, described as tiredness. L-NMNU significantly elevated mean arterial pressure by 12%*3%, due to an increase in systemic vascular resistance. Cardiac output decreased by 23%*3%. Heart rate was stable during infusion and increased slightly after the infusion. Mean pulmonary arterial pressure was stable while pulmonary vascular resistance tended to increase. Surprisingly, forearm vascular resistance decreased slightly, and forearm blood flow increased during the infusion despite the decrease in cardiac output. Bleeding time was shortened by 31 %*4%. LNMMA infusion decreased eNO by 64%*2% and eNO remained decreased more
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Abstracts from the Scandinavian Society of Anaesthesiologists, 30th Congress, 10-13 June 2009, Odense, Denmark. Abstracts from the 29th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, 5-8 September 2007, Goteborg, Sweden. CHAPTER 7 – Brain Resuscitation Abstracts from the 28th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Reykjavik, Iceland. Abstracts from the 27th Congress of The Scandinavian Society of Anaesthesiology and Intensive Care Medicine. August 16-20, 2003, Helsinki, Finland.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1